Coronary Artery Calcification and Complications in Patients With COVID-19

[1]  G. Fonarow,et al.  Association of Coronavirus Disease 2019 (COVID-19) With Myocardial Injury and Mortality. , 2020, JAMA cardiology.

[2]  Tao Guo,et al.  Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) , 2020, JAMA cardiology.

[3]  B. Song,et al.  Chest CT manifestations of new coronavirus disease 2019 (COVID-19): a pictorial review , 2020, European Radiology.

[4]  Yuan Wei,et al.  A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19 , 2020, The New England journal of medicine.

[5]  K. Yuen,et al.  Clinical Characteristics of Coronavirus Disease 2019 in China , 2020, The New England journal of medicine.

[6]  T. Wakefield,et al.  Empirical systemic anticoagulation is associated with decreased venous thromboembolism in critically ill influenza A H1N1 acute respiratory distress syndrome patients. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[7]  M. Blaha,et al.  Coronary Artery Calcium Scoring: Is It Time for a Change in Methodology? , 2017, JACC. Cardiovascular imaging.

[8]  M. Rubenfire,et al.  Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[9]  Klaus Mann,et al.  Coronary risk stratification, discrimination, and reclassification improvement based on quantification of subclinical coronary atherosclerosis: the Heinz Nixdorf Recall study. , 2010, Journal of the American College of Cardiology.